_id
691b18473c536f8df2318bfa
Ticker
OSE.PA
Name
OSE Pharma SA
Exchange
PA
Address
22, boulevard Benoni Goulin, Nantes, France, 44200
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.ose-immuno.com
Description
OSE Immunotherapeutics SA, a clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally. Its products include Tedopi that is in Phase III clinical trial for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; OSE-279, which is in a Phase I/II clinical trial in patients with advanced solid tumors or lymphomas; OSE-127, a humanized monoclonal antibody that is in Phase II clinical trial for the treatment of ulcerative colitis, as well as Sjögren's Syndrome; and FR104, which is in Phase I clinical trial for the treatment of rheumatoid arthritis. The company is also developing BI 765063, which is in Phase I clinical trial to treat solid tumors; OSE-230, an agonist antibody against ChemR23 to resolve chronic inflammation; CLEC-1, a therapeutic target in immune-oncology and identified monoclonal antibody antagonists; and BiCKI, a novel bispecific checkpoint inhibitor platform that targets PD-1 to fight primary and secondary resistance mechanisms developed by cancers. OSE Immunotherapeutics SA has collaborations and partnerships with GERCOR, ARCAGY-GINECO, Foundation FoRT, and Nantes University Hospital; and Boehringer Ingelheim, MabSilico, CKD, Servier, Veloxis Pharmaceuticals, and Chong Kun Dang Pharmaceutical Corporation. The company was formerly known as OSE Pharma SA and changed its name to OSE Immunotherapeutics SA in May 2016. OSE Immunotherapeutics SA was founded in 2012 and is headquartered in Nantes, France.
Last Close
5.25
Volume
67313
Current Price
4.96
Change
-0.07
Last Updated
2025-12-31T16:01:15.477Z
Image
https://logo.clearbit.com/www.ose-immuno.com
Ipo Date
-
Market Cap
117183880
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9955
Sentiment Sources
2
Rating
4.33
Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
1323000
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
23179000
Operating Income
-23488000
Interest Expense
1699000
Pretax Income
-18178000
Net Income
-15105000
Eps
-0.6829425678079908
Dividends Per Share
-
Shares Outstanding
22443522
Income Tax Expense
-3073000
EBITDA
-14848000
Operating Margin
-1775.3590325018897
Total Other Income Expense Net
5310000
Cash
25394000
Short Term Investments
16200000
Receivables
11676000
Inventories
-
Total Current Assets
55627000
Property Plant Equipment
4035000
Total Assets
104181000
Payables
8993000
Short Term Debt
6180000
Long Term Debt
-
Total Liabilities
53580000
Equity
50601000
Bs_currency_symbol
-
Depreciation
1632000
Change In Working Capital
-2590000
Cash From Operations
-17982000
Capital Expenditures
9000
Cash From Investing
30370000
Cash From Financing
-3740000
Net Change In Cash
8649000
Cf_currency_symbol
-
PE
-
PB
2.1679992284737453
ROE
-29.851188711685538
ROA
-14.498804964436893
FCF
-17991000
Fcf Percent
-13.598639455782314
Piotroski FScore
0
Health Score
24
Deep Value Investing Score
2.5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
3.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1323000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
23179000
Quarters > 0 > income Statement > operating Income
-23488000
Quarters > 0 > income Statement > interest Expense
1699000
Quarters > 0 > income Statement > pretax Income
-18178000
Quarters > 0 > income Statement > net Income
-15105000
Quarters > 0 > income Statement > eps
-0.6829425678079908
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
22117526
Quarters > 0 > income Statement > income Tax Expense
-3073000
Quarters > 0 > income Statement > EBITDA
-14848000
Quarters > 0 > income Statement > operating Margin
-1775.3590325018897
Quarters > 0 > income Statement > total Other Income Expense Net
5310000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
25394000
Quarters > 0 > balance Sheet > short Term Investments
16200000
Quarters > 0 > balance Sheet > receivables
11676000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
55627000
Quarters > 0 > balance Sheet > property Plant Equipment
4035000
Quarters > 0 > balance Sheet > total Assets
104181000
Quarters > 0 > balance Sheet > payables
8993000
Quarters > 0 > balance Sheet > short Term Debt
6180000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
53580000
Quarters > 0 > balance Sheet > equity
50601000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-15105000
Quarters > 0 > cash Flow > depreciation
1632000
Quarters > 0 > cash Flow > change In Working Capital
-2590000
Quarters > 0 > cash Flow > cash From Operations
-17982000
Quarters > 0 > cash Flow > capital Expenditures
9000
Quarters > 0 > cash Flow > cash From Investing
30370000
Quarters > 0 > cash Flow > cash From Financing
-3740000
Quarters > 0 > cash Flow > net Change In Cash
8649000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.6829425678079908
Quarters > 0 > ratios > PB
2.1679992284737453
Quarters > 0 > ratios > ROE
-29.851188711685538
Quarters > 0 > ratios > ROA
-14.498804964436893
Quarters > 0 > ratios > FCF
-17991000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-13.598639455782314
Quarters > 0 > health Score
24
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
831000
Quarters > 1 > income Statement > cost Of Revenue
831000
Quarters > 1 > income Statement > gross Profit
862000
Quarters > 1 > income Statement > operating Expenses
20451000
Quarters > 1 > income Statement > operating Income
-19586000
Quarters > 1 > income Statement > interest Expense
1437000
Quarters > 1 > income Statement > pretax Income
-20883000
Quarters > 1 > income Statement > net Income
-19730000
Quarters > 1 > income Statement > eps
-0.910601375363456
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
21667000
Quarters > 1 > income Statement > income Tax Expense
-1153000
Quarters > 1 > income Statement > EBITDA
-19442000
Quarters > 1 > income Statement > operating Margin
-2356.919374247894
Quarters > 1 > income Statement > total Other Income Expense Net
-1297000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
16745000
Quarters > 1 > balance Sheet > short Term Investments
42372000
Quarters > 1 > balance Sheet > receivables
4138000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
69932000
Quarters > 1 > balance Sheet > property Plant Equipment
3425000
Quarters > 1 > balance Sheet > total Assets
123959000
Quarters > 1 > balance Sheet > payables
3397000
Quarters > 1 > balance Sheet > short Term Debt
8389000
Quarters > 1 > balance Sheet > long Term Debt
35659000
Quarters > 1 > balance Sheet > total Liabilities
60148000
Quarters > 1 > balance Sheet > equity
63811000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-19730000
Quarters > 1 > cash Flow > depreciation
3310000
Quarters > 1 > cash Flow > change In Working Capital
-5597000
Quarters > 1 > cash Flow > cash From Operations
-18662000
Quarters > 1 > cash Flow > capital Expenditures
59000
Quarters > 1 > cash Flow > cash From Investing
8005000
Quarters > 1 > cash Flow > cash From Financing
1545000
Quarters > 1 > cash Flow > net Change In Cash
-59001000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.910601375363456
Quarters > 1 > ratios > PB
1.6841660528748963
Quarters > 1 > ratios > ROE
-30.919433953393614
Quarters > 1 > ratios > ROA
-15.916553053832317
Quarters > 1 > ratios > FCF
-18721000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-22.528279181708786
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
82573000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
69046000
Quarters > 2 > income Statement > operating Expenses
19252000
Quarters > 2 > income Statement > operating Income
46127000
Quarters > 2 > income Statement > interest Expense
1865000
Quarters > 2 > income Statement > pretax Income
57108000
Quarters > 2 > income Statement > net Income
57175000
Quarters > 2 > income Statement > eps
2.6276483294269037
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
21759000
Quarters > 2 > income Statement > income Tax Expense
3540000
Quarters > 2 > income Statement > EBITDA
60637000
Quarters > 2 > income Statement > operating Margin
55.862085669649886
Quarters > 2 > income Statement > total Other Income Expense Net
10981000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
75746000
Quarters > 2 > balance Sheet > short Term Investments
49908000
Quarters > 2 > balance Sheet > receivables
7554000
Quarters > 2 > balance Sheet > inventories
2466000
Quarters > 2 > balance Sheet > total Current Assets
85785000
Quarters > 2 > balance Sheet > property Plant Equipment
3647000
Quarters > 2 > balance Sheet > total Assets
140921000
Quarters > 2 > balance Sheet > payables
8344000
Quarters > 2 > balance Sheet > short Term Debt
3921000
Quarters > 2 > balance Sheet > long Term Debt
37151000
Quarters > 2 > balance Sheet > total Liabilities
59473000
Quarters > 2 > balance Sheet > equity
81448000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
57175000
Quarters > 2 > cash Flow > depreciation
1664000
Quarters > 2 > cash Flow > change In Working Capital
7577000
Quarters > 2 > cash Flow > cash From Operations
66633000
Quarters > 2 > cash Flow > capital Expenditures
18000
Quarters > 2 > cash Flow > cash From Investing
-54914000
Quarters > 2 > cash Flow > cash From Financing
-4534000
Quarters > 2 > cash Flow > net Change In Cash
57074000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
2.6276483294269037
Quarters > 2 > ratios > PB
1.3250741577448186
Quarters > 2 > ratios > ROE
70.19816324526079
Quarters > 2 > ratios > ROA
40.57237743132677
Quarters > 2 > ratios > FCF
66615000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.8067407021665678
Quarters > 2 > health Score
90
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
869000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
869000
Quarters > 3 > income Statement > operating Expenses
12325000
Quarters > 3 > income Statement > operating Income
-13152000
Quarters > 3 > income Statement > interest Expense
1361000
Quarters > 3 > income Statement > pretax Income
-14615000
Quarters > 3 > income Statement > net Income
-11143000
Quarters > 3 > income Statement > eps
-0.5435609756097561
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
20500000
Quarters > 3 > income Statement > income Tax Expense
-3472000
Quarters > 3 > income Statement > EBITDA
-11701000
Quarters > 3 > income Statement > operating Margin
-1513.4637514384349
Quarters > 3 > income Statement > total Other Income Expense Net
-1463000
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
18672000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1805000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
30478000
Quarters > 3 > balance Sheet > property Plant Equipment
4070000
Quarters > 3 > balance Sheet > total Assets
81900000
Quarters > 3 > balance Sheet > payables
6491000
Quarters > 3 > balance Sheet > short Term Debt
7261000
Quarters > 3 > balance Sheet > long Term Debt
35509000
Quarters > 3 > balance Sheet > total Liabilities
59079000
Quarters > 3 > balance Sheet > equity
22975000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-11143000
Quarters > 3 > cash Flow > depreciation
1729000
Quarters > 3 > cash Flow > change In Working Capital
303000
Quarters > 3 > cash Flow > cash From Operations
-8037000
Quarters > 3 > cash Flow > capital Expenditures
16000
Quarters > 3 > cash Flow > cash From Investing
-617000
Quarters > 3 > cash Flow > cash From Financing
12309000
Quarters > 3 > cash Flow > net Change In Cash
3654000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-0.5435609756097561
Quarters > 3 > ratios > PB
4.425680087051142
Quarters > 3 > ratios > ROE
-48.50054406964092
Quarters > 3 > ratios > ROA
-13.605616605616605
Quarters > 3 > ratios > FCF
-8053000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-9.266973532796317
Quarters > 3 > health Score
16
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
69877000
Annuals > 0 > income Statement > cost Of Revenue
69877000
Annuals > 0 > income Statement > gross Profit
69877000
Annuals > 0 > income Statement > operating Expenses
41519000
Annuals > 0 > income Statement > operating Income
43735000
Annuals > 0 > income Statement > interest Expense
3302000
Annuals > 0 > income Statement > pretax Income
39832000
Annuals > 0 > income Statement > net Income
37445000
Annuals > 0 > income Statement > eps
1.7170304475421863
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
21808000
Annuals > 0 > income Statement > income Tax Expense
2387000
Annuals > 0 > income Statement > EBITDA
41195000
Annuals > 0 > income Statement > operating Margin
62.58854844941827
Annuals > 0 > income Statement > total Other Income Expense Net
-3903000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
16745000
Annuals > 0 > balance Sheet > short Term Investments
42372000
Annuals > 0 > balance Sheet > receivables
4138000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
69932000
Annuals > 0 > balance Sheet > property Plant Equipment
3425000
Annuals > 0 > balance Sheet > total Assets
123959000
Annuals > 0 > balance Sheet > payables
3397000
Annuals > 0 > balance Sheet > short Term Debt
8389000
Annuals > 0 > balance Sheet > long Term Debt
35659000
Annuals > 0 > balance Sheet > total Liabilities
60148000
Annuals > 0 > balance Sheet > equity
63811000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
37445000
Annuals > 0 > cash Flow > depreciation
6257000
Annuals > 0 > cash Flow > change In Working Capital
1980000
Annuals > 0 > cash Flow > cash From Operations
48440000
Annuals > 0 > cash Flow > capital Expenditures
77000
Annuals > 0 > cash Flow > cash From Investing
-46909000
Annuals > 0 > cash Flow > cash From Financing
-3458000
Annuals > 0 > cash Flow > net Change In Cash
-1927000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
1.7170304475421863
Annuals > 0 > ratios > PB
1.7600601777123068
Annuals > 0 > ratios > ROE
58.681105138612466
Annuals > 0 > ratios > ROA
30.207568631563664
Annuals > 0 > ratios > FCF
48363000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.6921161469439158
Annuals > 0 > health Score
90
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2227000
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
2227000
Annuals > 1 > income Statement > operating Expenses
25213000
Annuals > 1 > income Statement > operating Income
-22986000
Annuals > 1 > income Statement > interest Expense
2269000
Annuals > 1 > income Statement > pretax Income
-23222000
Annuals > 1 > income Statement > net Income
-23003000
Annuals > 1 > income Statement > eps
-1.1759022594826705
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
19562000
Annuals > 1 > income Statement > income Tax Expense
-219000
Annuals > 1 > income Statement > EBITDA
-17501000
Annuals > 1 > income Statement > operating Margin
-1032.1508756174226
Annuals > 1 > income Statement > total Other Income Expense Net
-235000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
18672000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1805000
Annuals > 1 > balance Sheet > inventories
-982000
Annuals > 1 > balance Sheet > total Current Assets
30478000
Annuals > 1 > balance Sheet > property Plant Equipment
4070000
Annuals > 1 > balance Sheet > total Assets
82054000
Annuals > 1 > balance Sheet > payables
6360000
Annuals > 1 > balance Sheet > short Term Debt
7261000
Annuals > 1 > balance Sheet > long Term Debt
35509000
Annuals > 1 > balance Sheet > total Liabilities
59079000
Annuals > 1 > balance Sheet > equity
22821000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-23003000
Annuals > 1 > cash Flow > depreciation
3471000
Annuals > 1 > cash Flow > change In Working Capital
-835000
Annuals > 1 > cash Flow > cash From Operations
-19764000
Annuals > 1 > cash Flow > capital Expenditures
232000
Annuals > 1 > cash Flow > cash From Investing
-507000
Annuals > 1 > cash Flow > cash From Financing
13324000
Annuals > 1 > cash Flow > net Change In Cash
-6948000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-1.1759022594826705
Annuals > 1 > ratios > PB
4.41454362210245
Annuals > 1 > ratios > ROE
-100.79751106437054
Annuals > 1 > ratios > ROA
-28.03397762449119
Annuals > 1 > ratios > FCF
-19996000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-8.978895374943871
Annuals > 1 > health Score
15
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
18302000
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
18302000
Annuals > 2 > income Statement > operating Expenses
36778000
Annuals > 2 > income Statement > operating Income
-18476000
Annuals > 2 > income Statement > interest Expense
1372000
Annuals > 2 > income Statement > pretax Income
-23454000
Annuals > 2 > income Statement > net Income
-17760000
Annuals > 2 > income Statement > eps
-0.962236549818497
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
18457000
Annuals > 2 > income Statement > income Tax Expense
-5694000
Annuals > 2 > income Statement > EBITDA
-13113000
Annuals > 2 > income Statement > operating Margin
-100.95071576876845
Annuals > 2 > income Statement > total Other Income Expense Net
454000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
25620000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
8128000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
37200000
Annuals > 2 > balance Sheet > property Plant Equipment
4979000
Annuals > 2 > balance Sheet > total Assets
91670000
Annuals > 2 > balance Sheet > payables
4563000
Annuals > 2 > balance Sheet > short Term Debt
3976000
Annuals > 2 > balance Sheet > long Term Debt
37231000
Annuals > 2 > balance Sheet > total Liabilities
59123000
Annuals > 2 > balance Sheet > equity
32547000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-17760000
Annuals > 2 > cash Flow > depreciation
3537000
Annuals > 2 > cash Flow > change In Working Capital
-3142000
Annuals > 2 > cash Flow > cash From Operations
-18252000
Annuals > 2 > cash Flow > capital Expenditures
274000
Annuals > 2 > cash Flow > cash From Investing
26000
Annuals > 2 > cash Flow > cash From Financing
10267000
Annuals > 2 > cash Flow > net Change In Cash
-7959000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.962236549818497
Annuals > 2 > ratios > PB
2.9205011214551266
Annuals > 2 > ratios > ROE
-54.56724122038897
Annuals > 2 > ratios > ROA
-19.373840951238137
Annuals > 2 > ratios > FCF
-18526000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-1.0122390995519615
Annuals > 2 > health Score
25
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
26306000
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
26306000
Annuals > 3 > income Statement > operating Expenses
42931000
Annuals > 3 > income Statement > operating Income
-16625000
Annuals > 3 > income Statement > interest Expense
836000
Annuals > 3 > income Statement > pretax Income
-21558000
Annuals > 3 > income Statement > net Income
-16850000
Annuals > 3 > income Statement > eps
-0.928118975488846
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
18155000
Annuals > 3 > income Statement > income Tax Expense
-4708000
Annuals > 3 > income Statement > EBITDA
-13720000
Annuals > 3 > income Statement > operating Margin
-63.198509845662585
Annuals > 3 > income Statement > total Other Income Expense Net
-588000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
33579000
Annuals > 3 > balance Sheet > short Term Investments
-226000
Annuals > 3 > balance Sheet > receivables
1594000
Annuals > 3 > balance Sheet > inventories
2963000
Annuals > 3 > balance Sheet > total Current Assets
44206000
Annuals > 3 > balance Sheet > property Plant Equipment
5439000
Annuals > 3 > balance Sheet > total Assets
101521000
Annuals > 3 > balance Sheet > payables
2955000
Annuals > 3 > balance Sheet > short Term Debt
2367000
Annuals > 3 > balance Sheet > long Term Debt
30801000
Annuals > 3 > balance Sheet > total Liabilities
53986000
Annuals > 3 > balance Sheet > equity
47890000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-16850000
Annuals > 3 > cash Flow > depreciation
2606000
Annuals > 3 > cash Flow > change In Working Capital
1025000
Annuals > 3 > cash Flow > cash From Operations
-9919000
Annuals > 3 > cash Flow > capital Expenditures
472000
Annuals > 3 > cash Flow > cash From Investing
-827000
Annuals > 3 > cash Flow > cash From Financing
14957000
Annuals > 3 > cash Flow > net Change In Cash
4211000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.928118975488846
Annuals > 3 > ratios > PB
1.9523543537272918
Annuals > 3 > ratios > ROE
-35.184798496554606
Annuals > 3 > ratios > ROA
-16.597551245555106
Annuals > 3 > ratios > FCF
-10391000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.3950049418383639
Annuals > 3 > health Score
25
Valuation > metrics > PE
-0.6829425678079908
Valuation > metrics > PB
2.1679992284737453
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-29.851188711685538
Profitability > metrics > ROA
-27.154079853308644
Profitability > metrics > Net Margin
-11.417233560090702
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.0588723543012983
Risk > metrics > Interest Coverage
-13.824602707474986
Risk > final Score
-25
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.666183352006854
Liquidity > metrics > Quick Ratio
3.666183352006854
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
100
Prev Valuations > 2
35.74319912948858
Prev Profitabilities > 0
0
Prev Profitabilities > 1
100
Prev Profitabilities > 2
0
Prev Risks > 0
-7
Prev Risks > 1
88
Prev Risks > 2
-21
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:10:18.564Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-05-01
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.9
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.9
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2023-03-31
Earnings History > 2 > report Date
2023-04-27
Earnings History > 2 > date
2023-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
EUR
Earnings History > 2 > eps Actual
-0.85
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-06-30
Earnings History > 3 > report Date
2022-09-22
Earnings History > 3 > date
2022-06-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-0.11
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-12-31
Earnings History > 4 > report Date
2022-03-30
Earnings History > 4 > date
2021-12-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.93
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.93
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-06-30
Earnings History > 5 > report Date
2021-08-26
Earnings History > 5 > date
2021-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.64
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.64
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-12-31
Earnings History > 6 > report Date
2021-03-29
Earnings History > 6 > date
2020-12-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.84
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.84
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-06-30
Earnings History > 7 > report Date
2020-09-17
Earnings History > 7 > date
2020-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.21
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.21
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-12-31
Earnings History > 8 > report Date
2020-03-27
Earnings History > 8 > date
2019-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.31
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.31
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-06-30
Earnings History > 9 > report Date
2019-09-05
Earnings History > 9 > date
2019-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0.03
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0.03
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-28
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
0.35
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0.35
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-06-30
Earnings History > 11 > report Date
2018-09-06
Earnings History > 11 > date
2018-06-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
0.57
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.57
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-03-31
Earnings History > 12 > report Date
2018-04-27
Earnings History > 12 > date
2018-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.29
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.29
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-06-30
Earnings History > 13 > report Date
2017-09-07
Earnings History > 13 > date
2017-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.44
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.44
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-03-31
Earnings History > 14 > report Date
2017-04-28
Earnings History > 14 > date
2017-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.27
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.27
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-06-30
Earnings History > 15 > report Date
2016-09-09
Earnings History > 15 > date
2016-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
2.1
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
2.1
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2015-12-31
Earnings History > 16 > report Date
2016-03-21
Earnings History > 16 > date
2015-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.26
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.26
Earnings History > 16 > surprise Percent
-
OSE Immunotherapeutics SA, a clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally. Its products include Tedopi that is in Phase III clinical trial for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; OSE-279, which is in a Phase I/II clinical trial in patients with advanced solid tumors or lymphomas; OSE-127, a humanized monoclonal antibody that is in Phase II clinical trial for the treatment of ulcerative colitis, as well as Sjögren's Syndrome; and FR104, which is in Phase I clinical trial for the treatment of rheumatoid arthritis. The company is also developing BI 765063, which is in Phase I clinical trial to treat solid tumors; OSE-230, an agonist antibody against ChemR23 to resolve chronic inflammation; CLEC-1, a therapeutic target in immune-oncology and identified monoclonal antibody antagonists; and BiCKI, a novel bispecific checkpoint inhibitor platform that targets PD-1 to fight primary and secondary resistance mechanisms developed by cancers. OSE Immunotherapeutics SA has collaborations and partnerships with GERCOR, ARCAGY-GINECO, Foundation FoRT, and Nantes University Hospital; and Boehringer Ingelheim, MabSilico, CKD, Servier, Veloxis Pharmaceuticals, and Chong Kun Dang Pharmaceutical Corporation. The company was formerly known as OSE Pharma SA and changed its name to OSE Immunotherapeutics SA in May 2016. OSE Immunotherapeutics SA was founded in 2012 and is headquartered in Nantes, France.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AOSE Immunotherapeutics Shares Bounce Back at Close After Ambitious Strategic Plan Idéal Investisseur
Read more →Ose Immunotherapeutics stock falls after AbbVie deal amendment Investing.com
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Medium
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of OSE Pharma SA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-03-31
EPS Actual
-0.9
EPS Estimate
0
EPS Difference
-0.9
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.